United States Biotechnology & Medical Research

Fennec Pharmaceuticals Inc (FENC)

Track

Over the past 90 days, Fennec Pharmaceuticals Inc. saw 10 insider transactions resulting in a net negative value of approximately $211,361. Directors Rostislav Raykov and Chris Rallis were the primary participants, engaging in both buying and selling activity. These transactions occurred following the company's April 2026 earnings report, amid a 43.9% increase in stock price.
Ticker: FENC Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Fennec Pharmaceuticals Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Planned sale 1 Jul 2026
Value US$2,802,078.00 | Price 123.18 | Shares 20,772 (+39.4%)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-07-02 2026-07-01 PlS Planned sale
2.7
Raykov Rosty
20,772 +39.4%
123.18
US$2,802,078 		20,772 +39.4% 123.18 US$2,802,078
2026-07-01 2026-07-01 PrS Proposed sale
2.7
ROSTISLAV RAYKOV

Director

Non-Executive Director
10,518
447.78
US$2,420,849 		10,518 447.78 US$2,420,849
2026-06-04 2026-06-01 S Sale
3.1
Raykov, Rostislav Christov

Director of Issuer

Non-Executive Director
18,319 +1.4%
288.47
US$3,107,877 		18,319 +1.4% 288.47 US$3,107,877
2026-06-04 2026-06-01 B Purchase
3.1
Raykov, Rostislav Christov

Director of Issuer

Non-Executive Director
15,597 +0.6%
2.45
US$38,213 		15,597 +0.6% 2.45 US$38,213
2026-06-02 2026-06-01 PlS Planned sale
2.7
Raykov Rosty
Non-Executive Director
9,747 -7.0%
9.62
US$93,766 		9,747 -7.0% 9.62 US$93,766
2026-06-01 2026-06-01 PrS Proposed sale
2.7
ROSTISLAV RAYKOV

Director

Non-Executive Director
9,747
9.62
US$93,814 		9,747 9.62 US$93,814
2026-05-12 2026-05-11 S Sale
3.5
RALLIS CHRIS A
Non-Executive Director
8,346 -11.7%
7.04
US$58,756 		8,346 -11.7% 7.04 US$58,756
2026-05-11 2026-05-11 S Sale
3.5
Rallis, Chris Anigeron

Director of Issuer

Non-Executive Director
8,346 -12.0%
7.05
US$58,839 		8,346 -12.0% 7.05 US$58,839
2026-05-11 2026-05-11 B Purchase
3.5
Rallis, Chris Anigeron

Director of Issuer

Non-Executive Director
14,344 +25.9%
2.44
US$34,999 		14,344 +25.9% 2.44 US$34,999
2026-05-11 2026-05-11 PrS Proposed sale
3.5
CHRIS A RALLIS

Director

Non-Executive Director
8,346
7.05
US$58,833 		8,346 7.05 US$58,833
2026-05-01 2026-05-01 PlS Planned sale
2.7
Raykov Rosty
Non-Executive Director
10,781 -8.2%
6.47
US$69,753 		10,781 -8.2% 6.47 US$69,753
2026-05-01 2026-05-01 PrS Proposed sale
2.7
ROSTISLAV RAYKOV

Director

Non-Executive Director
10,781
6.47
US$69,762 		10,781 6.47 US$69,762
2026-04-02 2026-04-01 PlS Planned sale
2.7
Raykov Rosty
Non-Executive Director
10,946 -8.8%
6.31
US$69,069 		10,946 -8.8% 6.31 US$69,069
2026-04-01 2026-04-01 S Sale
3.1
Raykov, Rostislav Christov

Director of Issuer

Non-Executive Director
10,946 -0.4%
6.31
US$69,069 		10,946 -0.4% 6.31 US$69,069
2026-04-01 2026-04-01 B Purchase
3.1
Raykov, Rostislav Christov

Director of Issuer

Non-Executive Director
15,598 +0.6%
2.45
US$38,215 		15,598 +0.6% 2.45 US$38,215
2026-04-01 2026-04-01 PrS Proposed sale
2.7
ROSTISLAV RAYKOV

Director

Non-Executive Director
10,946
6.31
US$69,073 		10,946 6.31 US$69,073
2026-03-03 2026-03-02 S Sale
3.1
Raykov, Rostislav Christov

Director of Issuer

Non-Executive Director
10,079 -0.4%
8.37
US$84,361 		10,079 -0.4% 8.37 US$84,361
2026-03-03 2026-03-02 B Purchase
3.1
Raykov, Rostislav Christov

Director of Issuer

Non-Executive Director
15,598 +0.6%
2.45
US$38,215 		15,598 +0.6% 2.45 US$38,215
2026-03-03 2026-03-02 S Sale
2.7
Raykov Rosty
Non-Executive Director
10,079 -8.8%
8.36
US$84,260 		10,079 -8.8% 8.36 US$84,260
2026-03-02 2026-03-02 PrS Proposed sale
2.7
ROSTISLAV RAYKOV

Director

Non-Executive Director
10,079
8.37
US$84,354 		10,079 8.37 US$84,354
2026-02-24 2026-02-19 B Purchase
3.6
Andrade, Robert Christopher

Senior Officer of Issuer

Officer
2,450 +1.0%
4.08
US$9,996 		2,450 +1.0% 4.08 US$9,996
2026-02-02 2026-02-02 PrS Proposed sale
2.7
ROSTISLAV RAYKOV

Director

Non-Executive Director
10,349
7.76
US$80,339 		10,349 7.76 US$80,339
2026-02-02 2026-02-02 S Sale
3.1
Raykov, Rostislav Christov

Director of Issuer

Non-Executive Director
10,439
7.76
US$81,007 		10,439 7.76 US$81,007
2026-02-02 2026-02-02 B Purchase
3.1
Raykov, Rostislav Christov

Director of Issuer

Non-Executive Director
15,598 +0.6%
2.45
US$38,215 		15,598 +0.6% 2.45 US$38,215
2026-02-02 2026-02-02 S Sale
2.7
Raykov Rosty
Non-Executive Director
10,349 -9.5%
7.76
US$80,308 		10,349 -9.5% 7.76 US$80,308
2026-01-16 2026-01-14 B Purchase
3.6
Andrade, Robert Christopher

Senior Officer of Issuer

Officer
10,000 +4.1%
2.45
US$24,500 		10,000 +4.1% 2.45 US$24,500
2026-01-05 2026-01-02 S Sale
3.1
Raykov, Rostislav Christov

Director of Issuer

Non-Executive Director
10,312 -0.4%
7.61
US$78,474 		10,312 -0.4% 7.61 US$78,474
2026-01-05 2026-01-02 B Purchase
3.1
Raykov, Rostislav Christov

Director of Issuer

Non-Executive Director
15,598 +0.6%
2.45
US$38,215 		15,598 +0.6% 2.45 US$38,215
2026-01-05 2026-01-02 S Sale
2.7
Raykov Rosty
Non-Executive Director
10,312 -10.5%
7.60
US$78,371 		10,312 -10.5% 7.60 US$78,371
2026-01-02 2026-01-02 PrS Proposed sale
2.7
ROSTISLAV RAYKOV

Director

Non-Executive Director
10,312
7.61
US$78,471 		10,312 7.61 US$78,471
2025-12-29 2025-12-24 S Sale
3.4
Southpoint Capital Advisors LP
Large shareholder
1,000,000 -26.7%
7.50
US$7,500,000 		1,000,000 -26.7% 7.50 US$7,500,000
2025-12-24 2025-12-24 S Sale
3.2
Southpoint Capital Advisors LP

10% Security Holder of Issuer

Large shareholder
1,000,000 -26.7%
7.50
US$7,500,000 		1,000,000 -26.7% 7.50 US$7,500,000
2025-12-05 2025-12-05 PrS Proposed sale
2.7
ROSTISLAV RAYKOV

Director

Non-Executive Director
10,000
7.54
US$75,444 		10,000 7.54 US$75,444
2025-12-05 2025-12-05 S Sale
3.1
Raykov, Rostislav Christov

Director of Issuer

Non-Executive Director
10,000 -0.4%
7.54
US$75,400 		10,000 -0.4% 7.54 US$75,400
2025-12-05 2025-12-05 PlS Planned sale
2.7
Raykov Rosty
Non-Executive Director
10,000 -11.4%
7.54
US$75,400 		10,000 -11.4% 7.54 US$75,400
2025-12-24 2025-11-18 S Sale
3.2
Southpoint Capital Advisors LP

10% Security Holder of Issuer

Large shareholder
19,341 -0.5%
8.79
US$170,048 		19,341 -0.5% 8.79 US$170,048
2025-11-20 2025-11-18 S Sale
3.4
Southpoint Capital Advisors LP
Large shareholder
19,341 -0.5%
8.79
US$170,048 		19,341 -0.5% 8.79 US$170,048
2025-11-18 2025-11-17 S Sale
3.2
Southpoint Capital Advisors LP

10% Security Holder of Issuer

Large shareholder
85,918 -2.2%
8.79
US$755,193 		85,918 -2.2% 8.79 US$755,193
2025-11-17 2025-11-17 S Sale
3.4
Southpoint Capital Advisors LP
Large shareholder
85,918 -2.2%
8.79
US$755,193 		85,918 -2.2% 8.79 US$755,193
2025-11-18 2025-11-14 S Sale
3.2
Southpoint Capital Advisors LP

10% Security Holder of Issuer

Large shareholder
160,100 -4.0%
8.00
US$1,280,432 		160,100 -4.0% 8.00 US$1,280,432
2025-11-17 2025-11-14 S Sale
3.4
Southpoint Capital Advisors LP
Large shareholder
160,100 -4.0%
8.00
US$1,280,432 		160,100 -4.0% 8.00 US$1,280,432
2025-11-06 2025-11-05 S Sale
3.1
Raykov, Rostislav Christov

Director of Issuer

Non-Executive Director
10,000 -0.4%
8.10
US$81,000 		10,000 -0.4% 8.10 US$81,000
2025-11-06 2025-11-05 PlS Planned sale
2.7
Raykov Rosty
Non-Executive Director
10,000 -10.8%
8.10
US$81,000 		10,000 -10.8% 8.10 US$81,000
2025-11-05 2025-11-05 PrS Proposed sale
2.7
ROSTISLAV RAYKOV

Director

Non-Executive Director
10,000
8.11
US$81,082 		10,000 8.11 US$81,082
2025-10-14 2025-10-10 S Sale
3.5
RALLIS CHRIS A
Non-Executive Director
1,775 -3.0%
9.24
US$16,401 		1,775 -3.0% 9.24 US$16,401
2025-10-10 2025-10-10 PrS Proposed sale
3.5
CHRIS A RALLIS

Director

Non-Executive Director
1,775
9.24
US$16,401 		1,775 9.24 US$16,401
2025-10-10 2025-10-10 S Sale
3.5
Rallis, Chris Anigeron

Director of Issuer

Non-Executive Director
1,775 -3.1%
9.24
US$16,401 		1,775 -3.1% 9.24 US$16,401
2025-10-10 2025-10-10 B Purchase
3.5
Rallis, Chris Anigeron

Director of Issuer

Non-Executive Director
4,062 +7.7%
1.23
US$4,996 		4,062 +7.7% 1.23 US$4,996
2025-10-10 2025-10-09 S Sale
3.2
Southpoint Capital Advisors LP

10% Security Holder of Issuer

Large shareholder
20,609 -0.5%
9.35
US$192,614 		20,609 -0.5% 9.35 US$192,614
2025-10-09 2025-10-09 S Sale
3.4
Southpoint Capital Advisors LP
Large shareholder
20,609 -0.5%
9.35
US$192,614 		20,609 -0.5% 9.35 US$192,614
2025-10-10 2025-10-08 S Sale
3.2
Southpoint Capital Advisors LP

10% Security Holder of Issuer

Large shareholder
19,605 -0.5%
9.47
US$185,663 		19,605 -0.5% 9.47 US$185,663
2025-10-10 2025-10-08 B Purchase
3.1
Raykov, Rostislav Christov

Director of Issuer

Non-Executive Director
4,609 +0.2%
2.45
US$11,292 		4,609 +0.2% 2.45 US$11,292
2025-10-09 2025-10-08 S Sale
3.4
Southpoint Capital Advisors LP
Large shareholder
19,605 -0.5%
9.47
US$185,722 		19,605 -0.5% 9.47 US$185,722
2025-10-10 2025-10-07 S Sale
3.2
Southpoint Capital Advisors LP

10% Security Holder of Issuer

Large shareholder
26,900 -0.7%
9.59
US$257,893 		26,900 -0.7% 9.59 US$257,893
2025-10-09 2025-10-07 S Sale
3.4
Southpoint Capital Advisors LP
Large shareholder
26,900 -0.7%
9.59
US$257,893 		26,900 -0.7% 9.59 US$257,893
2025-10-06 2025-10-06 PrS Proposed sale
2.7
ROSTISLAV RAYKOV

Director

Non-Executive Director
10,000
9.79
US$97,868 		10,000 9.79 US$97,868
2025-10-06 2025-10-06 PlS Planned sale
2.7
Raykov Rosty
Non-Executive Director
10,000 -10.8%
9.78
US$97,800 		10,000 -10.8% 9.78 US$97,800
2025-09-16 2025-09-11 B Purchase
3.1
Raykov, Rostislav Christov

Director of Issuer

Non-Executive Director
36,207 +1.4%
2.45
US$88,707 		36,207 +1.4% 2.45 US$88,707
2025-09-04 2025-09-04 PrS Proposed sale
2.7
ROSTISLAV RAYKOV

Director

Non-Executive Director
10,000
8.92
US$89,220 		10,000 8.92 US$89,220
2025-09-04 2025-09-04 PlS Planned sale
2.7
Raykov Rosty
Non-Executive Director
10,000 -16.4%
8.92
US$89,200 		10,000 -16.4% 8.92 US$89,200
2025-08-05 2025-08-05 PrS Proposed sale
2.7
ROSTISLAV RAYKOV

Director

Non-Executive Director
10,000
8.09
US$80,933 		10,000 8.09 US$80,933
2025-08-05 2025-08-05 S Sale
3.1
Raykov, Rostislav Christov

Director of Issuer

Non-Executive Director
10,000 -0.4%
8.09
US$80,900 		10,000 -0.4% 8.09 US$80,900
2025-08-05 2025-08-05 PlS Planned sale
2.7
Raykov Rosty
Non-Executive Director
10,000 -15.2%
8.09
US$80,900 		10,000 -15.2% 8.09 US$80,900
2025-07-07 2025-07-07 S Sale
3.5
RALLIS CHRIS A
Non-Executive Director
1,119 -2.0%
8.71
US$9,746 		1,119 -2.0% 8.71 US$9,746
2025-07-07 2025-07-03 PlS Planned sale
2.7
Raykov Rosty
Non-Executive Director
10,000 -14.2%
8.61
US$86,100 		10,000 -14.2% 8.61 US$86,100
2025-07-04 2025-07-03 S Sale
3.1
Raykov, Rostislav Christov

Director of Issuer

Non-Executive Director
10,000 -0.4%
8.61
US$86,100 		10,000 -0.4% 8.61 US$86,100
2025-07-03 2025-07-03 PrS Proposed sale
2.7
ROSTISLAV RAYKOV

Director

Non-Executive Director
10,000
8.61
US$86,102 		10,000 8.61 US$86,102
2025-06-09 2025-06-05 S Sale
3.1
Raykov, Rostislav Christov

Director of Issuer

Non-Executive Director
10,000 -0.4%
7.78
US$77,800 		10,000 -0.4% 7.78 US$77,800
2025-06-06 2025-06-05 PlS Planned sale
2.7
Raykov Rosty
Non-Executive Director
10,000 -13.3%
7.78
US$77,800 		10,000 -13.3% 7.78 US$77,800
2025-06-05 2025-06-05 PrS Proposed sale
2.7
ROSTISLAV RAYKOV

Director

Non-Executive Director
10,000
7.78
US$77,781 		10,000 7.78 US$77,781
2025-06-04 2025-06-02 B Purchase
3.6
Andrade, Robert Christopher

Senior Officer of Issuer

Officer
8,220 +4.0%
5.10
US$41,922 		8,220 +4.0% 5.10 US$41,922
2025-05-19 2025-05-19 B Purchase
3.2
Hackman, Jeffrey

Director of Issuer, Senior Officer of Issuer

Executive Director
15,000
6.98
US$104,700 		15,000 6.98 US$104,700
2025-05-19 2025-05-19 B Purchase
2.5
Hackman Jeffrey S.

Chief Executive Officer

Executive Director
13,965 +1349.3%
6.99
US$97,615 		13,965 +1349.3% 6.99 US$97,615
2025-05-19 2025-05-16 S Sale
3.1
Raykov, Rostislav Christov

Director of Issuer

Non-Executive Director
16,667 -0.6%
6.78
US$113,002 		16,667 -0.6% 6.78 US$113,002
2025-05-19 2025-05-16 B Purchase
2.5
Hackman Jeffrey S.

Chief Executive Officer

Executive Director
1,035 +inf%
6.75
US$6,986 		1,035 +inf% 6.75 US$6,986
Explore more

More insider trading research around Fennec Pharmaceuticals Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America